Focus on: Reducing medication overload remains a challenge
By
Judith Garber
Shannon Brownlee
Apr 01, 2020
Operators can take preventive measures to reduce adverse drug events in their communities, these two authors assert.
CMS to test model for chronic ailments
By
Lois A. Bowers
Sep 01, 2015
Your residents who have diabetes, hypertension, coronary artery disease, mood disorders and other chronic conditions and are enrolled in Medicare Advantage plans may end up being part of a newly announced...
Hypertension, type 2 diabetes contribute to brain changes in Puerto Rican seniors
Apr 01, 2022
A high prevalence of hypertension and type 2 diabetes was seen among the Puerto Rican cohort; those with both have deteriorating patterns in major white matter tracts.
Racial disparities in treatment account for 20 percent of differences in BP control
Dec 17, 2021
Additionally, racial differences in visit attendance account for a smaller portion of differences in BP control.
Where dementia is most prevalent
By
Lois A. Bowers
Feb 03, 2016
A new tool from the federal government provides county- and state-level prevalence data for Alzheimer’s/dementia and 15 other chronic conditions.
Intervention delivered via web-based platform ups BP control
Dec 07, 2022
The rate of BP control was significantly higher after 12 months of multicomponent intervention, with reduction in SBP of −10.1 mm Hg.
COVID-19 vaccine priority populations vary by state, city: reports
By
Kimberly Bonvissuto
Dec 11, 2020
With the Food and Drug Administration’s vaccine advisory board recommending approval of the Pfizer-BioNTech COVID-19 vaccine for emergency use authorization on Thursday, two data analyses outline which...
BP genetic risk score linked to risk for CV events in type 2 diabetes
Apr 04, 2022
Each standard deviation increase in BP polygenic risk score was linked to a 12% increased hazard of adverse cardiovascular events.
Risk for stroke increased in association with insomnia symptoms
Jun 09, 2023
The association was stronger in participants younger than 50 years; mediators included diabetes, hypertension, heart disease and depression.
Controlling hypertension in older adults: Up dose or add new med?
Oct 05, 2021
There was a bigger drop in systolic blood pressure, but less intensification sustainability was seen with addition of a new medication versus maximizing dose of the current drug.